H. Fuchs

发表

The pattern of lung injury induced after pulmonary exposure to tumor necrosis factor-alpha depends on the route of administration.

H. D. Liggitt, H. Fuchs, R. Debs, 1990, Diagnostic microbiology and infectious disease.

Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.

H. Fuchs, B. Laube, R. M. Auci, 1996, American journal of respiratory and critical care medicine.

Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

H. Fuchs, B. Ramsey, A. Smith, 1997, The Journal of pediatrics.

Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.

D. Geddes, A. Bush, D. E. Tullis, 1995, European Respiratory Journal.

Interferon-gamma increases alveolar macrophage Ia antigen expression despite oral administration of dexamethasone to rats.

J. Shellito, H. Fuchs, C. Czarniecki, 1989, American journal of respiratory cell and molecular biology.

Immunomodulatory and Toxic Effects of Free and Liposome-encapsulated Tumor Necrosis Factor α in Rats

D. Liggitt, J. Shellito, H. Fuchs, 1990 .

Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.

H. Fuchs, A. Clark, I. Gonda, 1995, Chest.

Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.

D. Geddes, P. Shah, M. Hodson, 1995, Thorax.

Effects of Recombinant Human DNase Therapy on Healthcare use and Costs in Patients with Cystic Fibrosis

G. Oster, D. Huse, M. Regan, 1995, The Annals of pharmacotherapy.

Cellular influx and activation increase macrophage cytotoxicity and interleukin-1 elaboration during pulmonary inflammation in rats.

J. Shellito, H. Fuchs, M. Sniezek, 1988, The American review of respiratory disease.

Use of allophycocyanin allows quantitative description by flow cytometry of alveolar macrophage surface antigens present in low numbers of cells.

J. Shellito, H. Fuchs, J. McDowell, 1988, The American review of respiratory disease.

Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats.

D. Liggitt, J. Shellito, H. Fuchs, 1988, Journal of immunology.

Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin.

M. T. Wong, R. Wenzel, H. Fuchs, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon

H. D. Liggitt, J. Shellito, H. Fuchs, 1991, Infection and immunity.

Biodistribution, tissue reaction, and lung retention of pentamidine aerosolized as three different salts.

H. Fuchs, R. Debs, E. Brunette, 1990, The American review of respiratory disease.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

H. Fuchs, B. Ramsey, A. Smith, 1994, The New England journal of medicine.

Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation.

M. Cybulsky, M. Gimbrone, J. Baker, 1991, Journal of immunology.

Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.

R. Amin, H. Fuchs, R. Moss, 1996, American journal of respiratory and critical care medicine.

[Effect of metoprolol on the circulation after head trauma. Studies during continuous intravenous administration (author's transl)].

H. Herden, H. Fuchs, J. Welter, 1980, Deutsche medizinische Wochenschrift.

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

S. Shak, D. Geddes, M. Hodson, 1993, The Lancet.

[Splitting of kynurenine, oxykynurenine an related substances by the rat liver enzyme].

H. Fuchs, O. Wiss, 1950, Experientia.